
Bio-Rad Laboratories Inc. Class A
BIO
NYE

Sector: Healthcare
Industry: Diagnostics & Research
548.49
USD
29.63
(5.71%)
Optionable: Yes Market Cap: 15,409 M 90-day average vol: 174,950
Previous close: 518.86 Open: 529.25 Bid: 843.62 Ask: 843.62
52 week range
462.61 832.70
Last updated: Thursday 11th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 4.45 |
Price per Book TTM ($) | 1.78 |
PE Ratio (TTM) | -8.10 |
Book Value per Share ($) | 300.45 |
5 Year PE Range | 4.5 , 59.4 |
Returns
7 Day Return | -0.01% | |
1 Month Return | 5.10% | |
3 Month Return | 13.60% | |
1 Year Return | -28.19% | |
3 Year Return | 71.74% | |
5 Year Return | 154.06% | |
YTD Return | -27.41% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 57.69 |
14 Day SMA ($) | 542.02 |
14 Day EMA ($) | 535.78 |
Money Flow Index | 69.98 |
Average True Range | 17.15 |
50 Day SMA ($) | 515.10 |
200 Day SMA ($) | 602.62 |
ADX | 15.44 |
MACD | 8.63 |
Growth
Free Cash Flow QoQ Growth | -84.81% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 114.05% |
Revenue QoQ Growth | -4.46% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
Quidel (QDEL) Rallies 17.4% Since Posting Q4 Earnings Beat
Yahoo Finance 3/3/2022
Bio-Rad Announces Closing of $1.2 Billion Aggregate Senior Notes Offering
Yahoo Finance 3/2/2022
Patterson Companies (PDCO) Q3 Earnings Beat, Revenues Lag
Yahoo Finance 3/2/2022
Insulet (PODD) Product Volume Up, COVID-Led Softness Persists
Yahoo Finance 3/2/2022
Henry Schein (HSIC) Expands Data Analytics to Private Practices
Yahoo Finance 3/2/2022
Cooper Companies (COO) to Post Q1 Earnings: What's in Store?
Yahoo Finance 3/2/2022
What's in Store for Patterson Companies' (PDCO) Q3 Earnings?
Yahoo Finance 3/1/2022
SmileDirectClub (SDC) Q4 Earnings Lag Estimates, Margin Falls
Yahoo Finance 3/1/2022
Here's Why You Should Retain CVS Health (CVS) Stock for Now
Yahoo Finance 3/1/2022
National Vision (EYE) Q4 Earnings Top Estimates, Margins Down
Yahoo Finance 3/1/2022
DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Miss Estimates
Yahoo Finance 2/28/2022
Inari Medical (NARI) Gains 12.5% Despite In-Line Q4 Earnings
Yahoo Finance 2/28/2022
Here's Why You Should Invest In Henry Schein (HSIC) Now
Yahoo Finance 2/28/2022
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 59.217
Financials
BIO Income Statement
Annual
Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenues | 2,069 M | 2,133 M | 2,175 M | 2,019 M | 2,068 M | 2,160 M | 2,289 M | 2,312 M | 2,546 M | 2,923 M |
Cost of sales | 784 M | 807 M | 847 M | 766 M | 787 M | 824 M | 928 M | 920 M | 970 M | 1,148 M |
Gross operating profit | 1,155 M | 1,178 M | 1,179 M | 1,122 M | 1,138 M | 1,188 M | 1,223 M | 1,257 M | 1,438 M | 1,641 M |
Selling Gen & administrative expense | 682 M | 798 M | 808 M | 762 M | 815 M | 807 M | 835 M | 825 M | 800 M | 880 M |
Research & development expense | 209 M | 211 M | 220 M | 193 M | 206 M | 250 M | 199 M | 203 M | 227 M | 272 M |
Operating income | 264 M | 169 M | 150 M | 167 M | 118 M | 131 M | 189 M | 230 M | 411 M | 489 M |
floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other income net | 5 M | -9 M | -10 M | -9 M | -68 M | -29 M | 321 M | 2,024 M | 4,500 M | 4,931 M |
Pre-tax Income (EBT) | 230 M | 112 M | 132 M | 146 M | 42 M | 98 M | 513 M | 2,261 M | 4,908 M | 5,438 M |
Income taxes | 64 M | 35 M | 43 M | 37 M | 16 M | -24 M | 147 M | 502 M | 1,101 M | 1,192 M |
Net income from total operations | 166 M | 78 M | 89 M | 109 M | 26 M | 122 M | 366 M | 1,759 M | 3,806 M | 4,246 M |
Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total net income | 165 M | 78 M | 89 M | 109 M | 26 M | 122 M | 366 M | 1,759 M | 3,806 M | 4,246 M |
Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net income available for common | 166 M | 78 M | 89 M | 109 M | 26 M | 122 M | 366 M | 1,759 M | 3,806 M | 4,246 M |
Depreciation | 130 M | 147 M | 150 M | 132 M | 143 M | 149 M | 138 M | 134 M | 138 M | 134 M |
Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating income before depreciation (EBITDA) | 411 M | 321 M | 304 M | 299 M | 208 M | 270 M | 675 M | 2,419 M | 5,068 M | 5,574 M |
Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic EPS total | 5.79 | 2.72 | 3.08 | 3.87 | 0.96 | 4.12 | 12.25 | 58.93 | 127.86 | 142.33 |
Diluted EPS total | 5.72 | 2.69 | 3.05 | 3.85 | 0.95 | 4.07 | 12.1 | 58.27 | 126.2 | 140.56 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todayStand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!